PITTSBURGH, PA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)STANLEY M MARKS BLOOD CANCER RESEARCH FUND, founded in 2017, is a small nonprofit in the Diseases & Disorders sector that reported $859K in total revenue in fiscal year 2023. Revenue surged 30% from the prior year, signaling strong growth momentum.
THE STANLEY M. MARKS BLOOD CANCER RESEARCH FUND IS A PENNSYLVANIA NON- PROFIT CORPORATION DEDICATED TO SUPPORTING THE UPMC HILLMAN CANCER CENTER, WHICH DEVELOPS HIGHLY INNOVATIVE RESEARCH AIMED AT NEW AND MORE EFFECTIVE THERAPIES FOR PATIENTS WITH ALL TYPES OF CANCERS, AS WELL AS EARLY DETECTION AND PREVENTION STRATEGIES TO REDUCE THE BURDEN OF CANCER REGIONALLY, NATIONALLY, AND GLOBALLY.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $859,096 | $661,800 | +0.3% |
| Expenses | $865,849 | $637,448 | +0.4% |
| Net Income | $-6,753 | $24,352 | -1.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| STANLEY M MARKS | CHAIRMAN | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| PASCAL NARDELLI | PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JEANNE CALIGUIRI | VICE PRESIDE | 5.00 |
Officer
Director
|
$0 | $0 | $0 |
| KIRK KASZAK | TREASURER | 10.00 |
Officer
Director
|
$0 | $0 | $0 |
| HEATHER KEICHER | TREASURER | 10.00 |
Officer
Director
|
$20,000 | $0 | $20,000 |
| JOSEPH ASKAR | DIRECTOR | 1.00 |
Director
|
$5,000 | $0 | $5,000 |
| PAT GALLAGHER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOE CURTIN | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DAVID SWANSON | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $859,096 | $865,849 | $47,424 | $-6,753 |
| 2022 | $661,800 | $637,448 | $54,177 | $24,352 |
| 2021 | $685,456 | $671,675 | $29,825 | $13,781 |
| 2020 | $386,451 | $397,715 | $16,044 | $-11,264 |
| 2019 | $506,625 | $495,477 | $27,308 | $11,148 |
| 2018 | $364,793 | $348,633 | $16,160 | $16,160 |
Compare STANLEY M MARKS BLOOD CANCER RESEARCH FUND with other nonprofits in Pennsylvania and across the country.